- Poster presentation
- Open Access
A pilot study of varicella zoster infection among patients with fever and rash in a tertiary care centre
© Ojah et al; licensee BioMed Central Ltd. 2014
- Published: 27 May 2014
- Varicella Zoster Virus
- Tertiary Care Hospital
- Immunization Schedule
- National Immunization
- Varicella Zoster Virus Infection
Varicella zoster virus (VZV) causes mild self limiting illness in children. Older children and adults may present with atypical manifestations. At present VZV vaccine is not included in national immunization schedule. The study was undertaken to determine the presence of VZV infection in patients with acute febrile illness with rash.
Blood samples were collected from patients (n=36) with acute febrile illness with rash in a tertiary care hospital. IgM ELISA was performed according to manufacturer’s instructions (IBL International, Germany). Kit standards were used to obtain a standard curve. The results of the samples were interpreted from the standard curve.
All enrolled patients had fever with rash without evidence of vesicles. Majority, (n=29) were adults and 18 were male. Of the 14 (38.9%) that were positive by IgM ELISA for VZV, 5 (35.7%) belonged to the age group of 19-30 years, 4 (28.5%) were < 18 years and 2 (14.3%) in age group 51-60 years. All patients had normal platelet count except 9, who had mildly deranged platelet count (>1.5 to < 2 lakh /cumm). All sera that were tested were negative for Dengue NS1 antigen, IgM and IgG antibody capture ELISA (Panbio, Australia).
VZV may present with atypical manifestation. Non progression of rash to vesicle may warrant testing for VZV and other viruses in the absence of positive Dengue serology.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.